• Media type: E-Article
  • Title: Exploratory analysis of the effect of a controlled lifestyle intervention on inflammatory markers – the Healthy Lifestyle Community Programme (cohort 2)
  • Contributor: Koeder, Christian; Anand, Corinna; Husain, Sarah; Kranz, Ragna-Marie; Schoch, Nora; Alzughayyar, Dima; Bitterlich, Norman; Hahn, Andreas; Englert, Heike
  • imprint: Springer Science and Business Media LLC, 2023
  • Published in: BMC Nutrition
  • Language: English
  • DOI: 10.1186/s40795-023-00684-2
  • ISSN: 2055-0928
  • Keywords: Public Health, Environmental and Occupational Health ; Nutrition and Dietetics ; Endocrinology, Diabetes and Metabolism ; Medicine (miscellaneous)
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Chronic low-grade inflammation is associated with an increased risk of chronic disease and mortality. The objective of the study was to test the effect of a healthy lifestyle intervention on biomarkers of inflammation (among other risk markers).</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>We conducted a non-randomized controlled trial with mostly middle-aged and elderly participants from the general population in rural northwest Germany (intervention: <jats:italic>n</jats:italic> = 114; control: <jats:italic>n</jats:italic> = 87). The intervention consisted of a 1-year lifestyle programme focusing on diet (largely plant-based; strongest emphasis), physical activity, stress management, and social support. High-sensitivity C-reactive protein (hs-CRP) was assessed at baseline, 10 weeks, 6 months, and 1 year. Homocysteine (Hcy) was assessed at baseline, 10 weeks, and 1 year. Adiponectin (Apn) was assessed at baseline and 10 weeks. An exploratory analysis of these inflammatory markers assessing the between-group differences with ANCOVA was conducted.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>The 1-year trajectory of hs-CRP was significantly lower in the intervention group compared to control (between-group difference: -0.8 (95% CI -1.2, -0.3) mg/l; <jats:italic>p</jats:italic> = 0.001; adjusted for baseline). The 1-year trajectory of Hcy was non-significantly higher in the intervention compared to control (between-group difference: 0.2 (95% CI -0.3, 0.7) µmol/l; <jats:italic>p</jats:italic> = 0.439; adjusted for baseline). From baseline to 10 weeks, Apn decreased significantly more in the intervention group compared to control (between-group difference: -1.6 (95% CI -2.7, -0.5) µg/ml; <jats:italic>p</jats:italic> = 0.004; adjusted for baseline).</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Our study shows that healthy lifestyle changes can lower hs-CRP and Apn levels and are unlikely to significantly affect Hcy levels within 1 year.</jats:p> </jats:sec><jats:sec> <jats:title>Trial registration</jats:title> <jats:p>German Clinical Trials Register (DRKS; reference: <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://drks.de/search/de/trial/DRKS00018775">DRKS00018775</jats:ext-link>, registered 12 Sept 2019; retrospectively registered; <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.drks.de">www.drks.de</jats:ext-link>).</jats:p> </jats:sec>
  • Access State: Open Access